Free Trial
NASDAQ:CDIO

Cardio Diagnostics (CDIO) Stock Price, News & Analysis

Cardio Diagnostics logo
$1.97 +0.08 (+4.23%)
As of 10:36 AM Eastern
This is a fair market value price provided by Massive. Learn more.

About Cardio Diagnostics Stock (NASDAQ:CDIO)

Advanced

Key Stats

Today's Range
$1.90
▼
$1.96
50-Day Range
$1.60
▼
$2.07
52-Week Range
$0.97
▼
$7.91
Volume
619 shs
Average Volume
1.17 million shs
Market Capitalization
$5.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Cardio Diagnostics Holdings, Inc. develops blood-based tests and technology for cardiovascular disease assessment. Its platform combines genetic and epigenetic information with artificial intelligence to support more personalized evaluation of heart disease.

The company’s offerings include Epi+Gen CHD, designed to assess a person’s risk of coronary heart disease, and PrecisionCHD, a test intended to help identify coronary heart disease in people being evaluated for the condition. The tests are designed to complement clinical assessment and are not a substitute for care from a health professional.

Founded in 2017 and based in Chicago, Illinois, Cardio Diagnostics was co-founded by Meesha Dogan, who serves as its chief executive officer. The company focuses primarily on making its testing services available in the United States.

AI Generated. May Contain Errors.

Cardio Diagnostics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
6th Percentile Overall Score

CDIO MarketRank™: 
0.317892221925 of 5 stars

Cardio Diagnostics scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cardio Diagnostics has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Cardio Diagnostics has only been the subject of 1 research reports in the past 90 days.

  • Read more about Cardio Diagnostics' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cardio Diagnostics is -0.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cardio Diagnostics is -0.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Cardio Diagnostics has a P/B Ratio of 0.49. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.18% of the float of Cardio Diagnostics has been sold short.
  • Short Interest Ratio / Days to Cover

    Cardio Diagnostics has a short interest ratio ("days to cover") of 0.27, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cardio Diagnostics has recently increased by 62.77%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Cardio Diagnostics does not currently pay a dividend.

  • Dividend Growth

    Cardio Diagnostics does not have a long track record of dividend growth.

  • News Sentiment

    Cardio Diagnostics has a news sentiment score of -0.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Cardio Diagnostics this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Cardio Diagnostics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    8.99% of the stock of Cardio Diagnostics is held by insiders.

  • Percentage Held by Institutions

    8.06% of the stock of Cardio Diagnostics is held by institutions.

  • Read more about Cardio Diagnostics' insider trading history.
Receive CDIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardio Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CDIO Stock News Headlines

My public warning after 55 years of watching the markets
Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.tc pixel
See More Headlines

CDIO Stock Analysis - Frequently Asked Questions

Cardio Diagnostics' stock was trading at $2.71 at the start of the year. Since then, CDIO shares have decreased by 30.3% and is now trading at $1.89.

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) released its quarterly earnings data on Friday, November, 6th. The company reported ($0.59) earnings per share for the quarter. Cardio Diagnostics had a negative net margin of 40,543.75% and a negative trailing twelve-month return on equity of 89.41%.

Cardio Diagnostics's stock reverse split on Tuesday, May 13th 2025.The 1-30 reverse split was announced on Thursday, May 8th 2025. The number of shares owned by shareholders was adjusted after the market closes on Monday, May 12th 2025. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Shares of CDIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardio Diagnostics investors own include Riot Platforms (RIOT), Super Micro Computer (SMCI), Tesla (TSLA), SoundHound AI (SOUN), Oracle (ORCL), Archer Aviation (ACHR) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
11/06/2026
Today
11/16/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:CDIO
CIK
1870144
Fax
N/A
Employees
17
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.53)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.50 million
Net Margins
-40,543.75%
Pretax Margin
-40,537.50%
Return on Equity
-89.41%
Return on Assets
-82.81%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
17.42
Quick Ratio
17.42

Sales & Book Value

Annual Sales
$15.19 thousand
Price / Sales
384.01
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.82 per share
Price / Book
0.52

Miscellaneous

Outstanding Shares
2,960,000
Free Float
2,694,000
Market Cap
$5.83 million
Optionable
Not Optionable
Beta
2.32
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (NASDAQ:CDIO) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners